Dr. Schindler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
950 Campbell Avenue
Building 1, 6th Floor
West Haven, CT 06516Phone+1 203-932-5711Fax+1 203-937-3464- Is this information wrong?
Education & Training
- Veterans Affairs Connecticut Healthcare SystemFellowship, Clinical Neuropharmaoclogical Research in Headache Medicine, 2016 - 2018
- Yale-New Haven Medical CenterResidency, Neurology, 2013 - 2016
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2013
- Drexel University College of MedicineClass of 2012
Certifications & Licensure
- CT State Medical License 2016 - 2024
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Psilocybin for the Treatment of Cluster Headache Start of enrollment: 2016 Dec 05
- Psilocybin for the Treatment of Migraine Headache Start of enrollment: 2017 Nov 01
- Effects of Psilocybin in Concussion Headache Start of enrollment: 2019 Mar 28
Publications & Presentations
PubMed
- Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.R Andrew Sewell, Christopher H Gottschalk, L Taylor Flynn, Yutong Zhu, Brian P Pittman, Nicholas V Cozzi, Deepak C D'Souza, Emmanuelle A D Schindler> ;Journal of the Neurological Sciences. 2024 Apr 2
- Adapting psychedelic medicine for headache and chronic pain disorders.Emmanuelle A D Schindler, Peter S Hendricks> ;Expert Review of Neurotherapeutics. 2023 Aug 31
- 1 citationsThe Potential of Psychedelics for the Treatment of Episodic Migraine.Emmanuelle A D Schindler> ;Current Pain and Headache Reports. 2023 Sep 1
- Join now to see all
Press Mentions
- The Psychedelic Remedy for Chronic PainOctober 1st, 2022
- Why Magic Mushrooms Are Emerging as Major Part of Public Discourse: What Science Is SayingSeptember 23rd, 2022
- electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic HeadacheMay 4th, 2021
- Join now to see all
Research History
- Advanced Research FellowIn my fellowship at VA Connecticut Healthcare System, I developed and executed the first controlled human trials of psilocybin in headache disorders (and any neurological disorder).2016 - 2018
- Graduate studentAs a graduate student at Drexel, I studied the neuropharmacology of 5-hydroxytryptamine (5-HT)2A receptor compounds, outlining biochemical and behavioral effects in the context of receptor binding and intracellular signaling.2005 - 2010
Professional Memberships
- Member
- American Headache SocietyMember
- Headache Cooperative of New EnglandMember
- International Society for Research on PsychedelicsMember
Other Languages
- French
Hospital Affiliations
- Veterans Affairs Connecticut Healthcare SystemWest Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: